-
Joint R&D on a CGM device with cardiovascular biomarkers for early heart disease and diabetes detection. -
Supported under the Indo-Canada Collaborative Programme with Nanospeed Diagnostics Inc. -
Real-time, remote monitoring to enhance preventive care and reduce reliance on hospital visits.
In line with the Government of India’s commitment to enhancing preventive healthcare and promoting indigenously developed medical technologies, the Technology Development Board (TDB) of the Department of Science & Technology (DST) has entered into a significant collaboration with M/s Drstore Healthcare Service India Pvt. Ltd., Maharashtra. The agreement is for a joint research and development (R&D) project in the digital health domain, which has been supported with grant assistance from TDB. The project, titled ‘Multivital Continuous Glucose Monitoring (CGM) Device with Cardiovascular Biomarkers for Early Detection of Heart Conditions alongside Diabetes Monitoring’, aims to address critical healthcare challenges by integrating cutting-edge technology into the healthcare ecosystem.
The project is being supported under the Indo-Canada Collaborative Industrial Research & Development Programme, a bilateral framework between the Department of Science & Technology, Government of India, and Canada’s National Research Council (NRC) and Global Affairs Canada. This programme fosters industry-driven, market-oriented R&D initiatives designed to develop commercially viable technologies with substantial societal impact. The Indian project is being carried out in collaboration with M/s Nanospeed Diagnostics Inc., a Canadian project partner.
The initiative seeks to combine advanced cardio-metabolic biomarkers such as B-type Natriuretic Peptide (BNP), Troponin-I, and high-sensitivity C-Reactive Protein (hs-CRP) into the existing continuous glucose monitoring system (CGM). This technology, which analyzes interstitial fluid, will allow simultaneous, continuous monitoring of both glucose levels and early cardiovascular risk indicators, aiming to tackle co-morbidities commonly associated with diabetes. By integrating these biomarkers, the technology will offer an innovative solution for the early detection and monitoring of heart conditions alongside diabetes.
Also Read: MediSim VR & Krupanidhi Group Forge Partnership for Advanced Medical Training
This integrated system has the potential to revolutionize healthcare by enabling real-time, remote monitoring of both glucose and cardiovascular biomarkers. It is expected to significantly improve preventive care, particularly for high-risk populations, by offering continuous monitoring outside of clinical settings and reducing reliance on episodic diagnostics or hospital-based care. The project aligns with national healthcare priorities, such as increasing affordable healthcare access, advancing digital health adoption, and developing indigenous medical technologies.
M/s Drstore Healthcare Service India Pvt. Ltd., which was established in 2015, focuses on developing solutions for preventive healthcare and remote monitoring. With the support of TDB, the company aims to validate the feasibility of this technology and create a pathway for its commercial deployment as a multi-vital health monitoring platform tailored for the Indian healthcare landscape.
In a statement, Rajesh Kumar Pathak, Secretary of TDB, emphasized that technology-driven preventive healthcare solutions are crucial for addressing the long-term disease burden in India. He noted that collaborations under international frameworks, such as the Indo-Canada Programme, provide Indian industries with access to global knowledge while enabling the development of scalable, indigenous solutions that cater to national health priorities. This initiative reflects TDB’s mission to foster innovation, promote international technology partnerships, and accelerate the commercialization of indigenous healthcare technologies, contributing to improved health outcomes and the growth of India’s medical technology ecosystem.
link